半乳糖凝集素治療公司
US ˙ NasdaqCM ˙ US3632252025

SecurityGALT / Galectin Therapeutics Inc.
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership799,846 shares
Latest Disclosed Value $ 2,287,000
Advisor Group, Inc. reports 2.97% increase in ownership of GALT / Galectin Therapeutics Inc.

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 799,846 shares of Galectin Therapeutics Inc. (US:GALT) valued at $2,287,560 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 776,802 shares of Galectin Therapeutics Inc.. This represents a change in shares of 2.97% during the quarter. The current value of the position is $1,859,642 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 799,846 23,044 2.97 2,287 -19.75 0.0158
2019-11-13 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 776,802 -30,373 -3.76 2,850 -14.93 0.0210
2019-07-31 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 807,175 114,586 16.54 3,350 -5.34 0.0257
2019-05-09 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 692,589 18,298 2.71 3,539 53.00 0.0291
2019-02-11 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 674,291 76,489 12.80 2,313 -35.62 0.0227
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 597,802 -15,162 -2.47 3,593 -7.82 0.0362
2018-08-13 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 612,964 56,587 10.17 3,898 47.82 0.0536
2018-05-15 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 556,377 25,527 4.81 2,637 48.73 0.0362
2018-02-14 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 530,850 11,000 2.12 1,773 59.44 0.0237
2017-11-06 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 519,850 35,850 7.41 1,112 -6.63 0.0175
2017-11-03 2017-06-30 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 484,000 45,700 10.43 1,191 18.15 0.0209
2017-08-11 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 484,000 45,700 1,191
2017-11-02 2017-03-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 438,300 67,475 18.20 1,008 177.69 0.0204
2017-05-15 2017-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 438,300 67,475 1,008
2017-11-02 2016-12-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 370,825 -42,300 -10.24 363 -22.27 0.0082
2017-01-31 2016-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 370,825 -42,300 363
2017-11-02 2016-09-30 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 413,125 15,200 3.82 467 -20.03 0.0112
2016-11-08 2016-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 413,125 15,200 467
2016-08-11 2016-06-30 13F GALECTIN THERAPEUTICS COM 363225202 397,925 584
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.